Overview

A Single Ascending Dose Study in Healthy Participants and Multiple Ascending Dose Study of CNTO 7160 in Participants With Asthma and Participants With Atopic Dermatitis

Status:
Completed
Trial end date:
2017-03-16
Target enrollment:
Participant gender:
Summary
The purpose of this study is to evaluate the safety and tolerability of single ascending dose of CNTO 7160 administered intravenously (IV) in healthy participants and multiple dose administered IV in participants with asthma and atopic dermatitis.
Phase:
Phase 1
Details
Lead Sponsor:
Janssen Research & Development, LLC